Transactive response DNA-binding Protein (TDP-43) regulates early HIV-1 entry and infection
Abstract The transactive response DNA-binding protein (TDP-43) is an important regulator of mRNA, being reported to stabilize the anti-HIV factor, histone deacetylase 6 (HDAC6). However, little is known about the role of TDP-43 in HIV infection. In this work, we seek for the TDP-43 function on regulating CD4+ T cell permissibility to HIV infection. We observed that over-expression of wt-TDP-43 in CD4+ T cells stabilized HDAC6, increasing mRNA and the protein levels of this antiviral enzyme. Under this experimental condition, HIV-1 infection was impaired, independently of the viral envelope glycoprotein (Env) complex tropism. The results obtained by using an HIV-1 Env-mediated cell-to-cell fusion model, under the same experimental conditions, suggest that the increase in TDP-43 levels negatively affects the viral Env fusion capacity. Moreover, the specific siRNA silencing of endogenous TDP-43 in target cells lead to a significant decrease in the levels of HDAC6 which consistently induces an increase in the fusogenic and infection activities of the HIV-1 Env. These observations were confirmed by using primary viral Envs from HIV+ individuals with different clinical phenotypes. An increase in the level of expression of wt-TDP-43 strongly reduced the Envs infection activity of viremic non-progressors (VNP) and rapid progressors (RP) HIV+ individuals down to the levels of the inefficient HIV-1 Envs from long-term non-progressor elite controllers (LTNP-EC) individuals. On the contrary, low levels of endogenous TDP-43, obtained after specific siRNA-TDP-43 knocking-down, significantly favors the infection activity of primary HIV-1 Envs of VNP and RP individuals, leading to an increase in the infection ability of the primary HIV-1/LTNP-EC Envs. Based on this evidence, we interpret that TDP-43 conditions cell permissibility to HIV infection by affecting viral Env fusion and infection capacities, at least by altering the cellular levels of the antiviral enzyme HDAC6..
Medienart: |
Preprint |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
bioRxiv.org - (2021) vom: 10. Dez. Zur Gesamtaufnahme - year:2021 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cabrera-Rodríguez, Romina [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
doi: |
10.1101/2021.12.06.471424 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
XBI033176736 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | XBI033176736 | ||
003 | DE-627 | ||
005 | 20230429085158.0 | ||
007 | cr uuu---uuuuu | ||
008 | 211209s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1101/2021.12.06.471424 |2 doi | |
035 | |a (DE-627)XBI033176736 | ||
035 | |a (biorXiv)10.1101/2021.12.06.471424 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 570 |q DE-84 | |
100 | 1 | |a Cabrera-Rodríguez, Romina |e verfasserin |4 aut | |
245 | 1 | 0 | |a Transactive response DNA-binding Protein (TDP-43) regulates early HIV-1 entry and infection |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract The transactive response DNA-binding protein (TDP-43) is an important regulator of mRNA, being reported to stabilize the anti-HIV factor, histone deacetylase 6 (HDAC6). However, little is known about the role of TDP-43 in HIV infection. In this work, we seek for the TDP-43 function on regulating CD4+ T cell permissibility to HIV infection. We observed that over-expression of wt-TDP-43 in CD4+ T cells stabilized HDAC6, increasing mRNA and the protein levels of this antiviral enzyme. Under this experimental condition, HIV-1 infection was impaired, independently of the viral envelope glycoprotein (Env) complex tropism. The results obtained by using an HIV-1 Env-mediated cell-to-cell fusion model, under the same experimental conditions, suggest that the increase in TDP-43 levels negatively affects the viral Env fusion capacity. Moreover, the specific siRNA silencing of endogenous TDP-43 in target cells lead to a significant decrease in the levels of HDAC6 which consistently induces an increase in the fusogenic and infection activities of the HIV-1 Env. These observations were confirmed by using primary viral Envs from HIV+ individuals with different clinical phenotypes. An increase in the level of expression of wt-TDP-43 strongly reduced the Envs infection activity of viremic non-progressors (VNP) and rapid progressors (RP) HIV+ individuals down to the levels of the inefficient HIV-1 Envs from long-term non-progressor elite controllers (LTNP-EC) individuals. On the contrary, low levels of endogenous TDP-43, obtained after specific siRNA-TDP-43 knocking-down, significantly favors the infection activity of primary HIV-1 Envs of VNP and RP individuals, leading to an increase in the infection ability of the primary HIV-1/LTNP-EC Envs. Based on this evidence, we interpret that TDP-43 conditions cell permissibility to HIV infection by affecting viral Env fusion and infection capacities, at least by altering the cellular levels of the antiviral enzyme HDAC6. | ||
700 | 1 | |a Pérez-Yanes, Silvia |e verfasserin |4 aut | |
700 | 1 | |a González-Montelongo, Rafaela |e verfasserin |4 aut | |
700 | 1 | |a Lorenzo-Salazar, José M. |e verfasserin |4 aut | |
700 | 1 | |a Estévez-Herrera, Judith |e verfasserin |4 aut | |
700 | 1 | |a García-Luis, Jonay |e verfasserin |4 aut | |
700 | 1 | |a Íñigo-Campos, Antonio |e verfasserin |4 aut | |
700 | 1 | |a Rubio-Rodríguez, Luis A. |e verfasserin |4 aut | |
700 | 1 | |a Muñoz-Barrera, Adrián |e verfasserin |4 aut | |
700 | 1 | |a Trujillo-González, Rodrigo |e verfasserin |4 aut | |
700 | 1 | |a Dorta-Guerra, Roberto |e verfasserin |4 aut | |
700 | 1 | |a Casado, Concha |e verfasserin |4 aut | |
700 | 1 | |a Pernas, María |e verfasserin |4 aut | |
700 | 1 | |a Blanco, Julià |e verfasserin |4 aut | |
700 | 1 | |a Flores, Carlos |e verfasserin |4 aut | |
700 | 1 | |a Valenzuela-Fernández, Agustín |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2021) vom: 10. Dez. |
773 | 1 | 8 | |g year:2021 |g day:10 |g month:12 |
856 | 4 | 0 | |u http://dx.doi.org/10.1101/2021.12.06.471424 |z kostenfrei |3 Volltext |
912 | |a GBV_XBI | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |j 2021 |b 10 |c 12 | ||
953 | |2 045F |a 570 |